MDxHealth Acquires NovioGendix to Expand Uro-Oncology Product Offering

Go back to MDxHealth Acquires NovioGendix to Expand Uro-Oncology Product Offering
(NASDAQ: MDXH) Delayed: 0.74 +0.02 (2.78%)
Previous Close $0.72    52 Week High
Open $0.72    52 Week Low
Day High $0.75    P/E N/A 
Day Low $0.71    EPS
Volume 396,459